Instrument Inactif

Communiqués VLOV Inc. Other OTC

Actions

US9182583024

Produits pharmaceutiques

Cours en clôture Other OTC
- ^USD	-

04/10/19

Kali-Extracts, Inc. fournit des prévisions de revenus pour le quatrième trimestre de 2019.

Communiqués

13/04/21	Kali : PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment	AQ
13/04/21	PAOG Announces Opportunity To Expand CBD Pharmaceutical Research	NE
13/01/21	PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow	NE
12/01/21	PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021	NE
11/01/21	PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2020	NE
08/01/21	PAOG Confirms Q4 2020 Revenue from Cannabis Asset Acquisition	NE
22/12/20	PAOG Expects to Report First Post Acquisition Revenue in Q4 2020	NE
23/10/20	Kali : PAOG Announces CRO Agreement To Advance Respiratory Cannabis Treatment Through Regulatory Approval	PR
20/10/20	Kali : PAOG - New Independent CBD Research Appears To Support PAOG RespRx Research	PR
20/10/20	Kali : PAOG FDA Application Process For Respiratory Cannabis Drug Treatment Update Scheduled This Friday	PR
16/10/20	PAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp Awareness	NE
01/10/20	PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND	NE
30/09/20	PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction	NE
24/09/20	PAOG Expands Cannabis Pharma Treatment Research	NE
30/07/20	PAOG Announces Acquisition of Resprx Entering $200B Biopharma Market	NE
28/07/20	PAOG Acquires Revenue Generating Cannabis Cultivation Operation Developing Proprietary Cultivar For Medical Research	NE
24/07/20	PAOG Schedules Acquisition Closing Dates For Tuesday and Thursday Next Week	NE
21/07/20	PAOG Plans Two Acquisitions In $100 Billion Medical Cannabis Market By Month End	NE
16/07/20	CORRECTION FROM SOURCE: KALY Exits Cannabis Business With Shareholder Cannabis Dividend	NE
16/07/20	KALY Calls for Partners on Patented Technology and Potential COVID-19 Treatment	NE
13/07/20	PURA Stock Dividend Reveal Set For Tomorrow	NE
10/07/20	PURA Cannabis Cultivation Spinoff and Dividend Breaking News Update	NE
09/07/20	PURA Shareholder Dividend Back On Track	NE
02/03/20	Kali : KALY Evaluates Patented Cannabis Extract for Potential Coronavirus Treatment	PR
04/02/20	Kali : KALY Announces $20 Million LOI to Fund Cannabis Biopharmaceutical Technology	PR